Alluvi Retatrutide 40mg

Alluvi Retatrutide 40mg – High-Dose Triple Agonist for Advanced Metabolic Research

Alluvi Retatrutide 40mg is a high-dose, research-grade peptide designed to support cutting-edge investigations in metabolic health, obesity, and glucose regulation. Retatrutide is a next-generation triple hormone receptor agonist that simultaneously targets GLP-1, GIP, and glucagon receptors, offering a comprehensive and synergistic approach to studying complex metabolic pathways.

This 40mg formulation delivers enhanced flexibility and precision for researchers requiring higher dosing protocols, making it ideal for extended or high-intensity studies.

Key Benefits:

• Triple Receptor Activation: Retatrutide activates GLP-1, GIP, and glucagon receptors to regulate appetite, insulin sensitivity, and energy expenditure.

• High-Concentration Formulation: Each vial contains 40mg of pharmaceutical-grade retatrutide for extended dosing flexibility in advanced research applications.

• Supports Broad Metabolic Studies: Ideal for research in obesity, type 2 diabetes, insulin resistance, lipid metabolism, and related metabolic conditions.

• Ultra-Pure Peptide: Manufactured to rigorous standards to ensure high purity, sterility, and stability for reproducible research outcomes.

Research Applications:

• Obesity and Appetite Regulation: Supports research on weight loss mechanisms through reduced caloric intake and increased metabolic activity.

• Diabetes and Insulin Response: Assists in the study of insulin secretion, glucose homeostasis, and resistance pathways.

• Cardiometabolic Health: Offers insights into lipid metabolism and cardiovascular risk factors in metabolic syndrome models.

Product Specifications:

• Content: 40mg lyophilized retatrutide peptide per vial

• Purity: ≥98% (HPLC tested)

• Form: Lyophilized powder

• Storage: Store at -20°C; reconstitute with sterile bacteriostatic water before use

For Research Use Only

Alluvi Retatrutide 40mg is intended strictly for laboratory and research purposes. It is not for human or veterinary use and is not approved for diagnostic or therapeutic applications.

Explore the next level of metabolic research with Alluvi Retatrutide 40mg. Engineered for precision and performance, this advanced peptide is a powerful tool for scientific discovery in metabolic and hormonal health.